These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 25758353)

  • 1. How to predict and treat increased fracture risk in chronic kidney disease.
    West SL; Patel P; Jamal SA
    J Intern Med; 2015 Jul; 278(1):19-28. PubMed ID: 25758353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.
    Bover J; Bailone L; López-Báez V; Benito S; Ciceri P; Galassi A; Cozzolino M
    J Nephrol; 2017 Oct; 30(5):677-687. PubMed ID: 28432640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fracture risk and treatment in chronic kidney disease.
    Connelly K; Collister D; Tangri N
    Curr Opin Nephrol Hypertens; 2018 May; 27(3):221-225. PubMed ID: 29547405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractures in chronic kidney disease: pursuing the best screening and management.
    Goldenstein PT; Jamal SA; Moysés RM
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):317-23. PubMed ID: 26050117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rational guide to reducing fracture risk in dialysis patients.
    Toussaint ND; Elder GJ; Kerr PG
    Semin Dial; 2010; 23(1):43-54. PubMed ID: 20331818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of bone mineral density measured by dual energy X-ray absorptiometry (DXA) and peripheral quantitative computed microtomography in chronic kidney disease.
    Jannot M; Mac-Way F; Lapierre V; Lafage-Proust MH
    J Nephrol; 2017 Oct; 30(5):635-643. PubMed ID: 28900872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis management in patient with renal function impairment.
    Lima GA; Paranhos Neto Fde P; Pereira GR; Gomes CP; Farias ML
    Arq Bras Endocrinol Metabol; 2014 Jul; 58(5):530-9. PubMed ID: 25166044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of bone architecture and strength in men and women with stage 5 chronic kidney disease.
    West SL; Jamal SA
    Semin Dial; 2012 Jul; 25(4):397-402. PubMed ID: 22686655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of osteoporosis in patients with chronic kidney disease.
    Abdalbary M; Sobh M; Elnagar S; Elhadedy MA; Elshabrawy N; Abdelsalam M; Asadipooya K; Sabry A; Halawa A; El-Husseini A
    Osteoporos Int; 2022 Nov; 33(11):2259-2274. PubMed ID: 35748896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low bone mineral density and fractures in stages 3-5 CKD: an updated systematic review and meta-analysis.
    Bucur RC; Panjwani DD; Turner L; Rader T; West SL; Jamal SA
    Osteoporos Int; 2015 Feb; 26(2):449-58. PubMed ID: 25477230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mass measurements in men and women with chronic kidney disease.
    Jamal SA
    Curr Opin Nephrol Hypertens; 2010 Jul; 19(4):343-8. PubMed ID: 20414109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of dual energy X-ray absorptiometry, the trabecular bone score and quantitative computed tomography in the evaluation of chronic kidney disease-mineral and bone disorders.
    Pocock N
    Nephrology (Carlton); 2017 Mar; 22 Suppl 2():19-21. PubMed ID: 28429557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis and adynamic bone in chronic kidney disease.
    Cannata-Andía JB; Rodriguez García M; Gómez Alonso C
    J Nephrol; 2013; 26(1):73-80. PubMed ID: 23023723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review and perspective on the assessment, management and prevention of fragility fractures in patients with osteoporosis and chronic kidney disease.
    Hampson G; Elder GJ; Cohen-Solal M; Abrahamsen B
    Endocrine; 2021 Sep; 73(3):509-529. PubMed ID: 33974225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical applications of bone density testing for osteoporosis.
    Lewiecki EM
    Minerva Med; 2005 Oct; 96(5):317-30. PubMed ID: 16227947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease.
    Jamal S; Cheung AM; West S; Lok C
    Osteoporos Int; 2012 Dec; 23(12):2805-13. PubMed ID: 22297732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density predicts fractures in chronic kidney disease.
    West SL; Lok CE; Langsetmo L; Cheung AM; Szabo E; Pearce D; Fusaro M; Wald R; Weinstein J; Jamal SA
    J Bone Miner Res; 2015 May; 30(5):913-9. PubMed ID: 25400209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fracture risk assessment in patients with chronic kidney disease.
    Jamal SA; West SL; Miller PD
    Osteoporos Int; 2012 Apr; 23(4):1191-8. PubMed ID: 21901475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of osteoporosis in chronic renal disease.
    Miller PD
    Semin Nephrol; 2009 Mar; 29(2):144-55. PubMed ID: 19371805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.